Exter Neil 4
4 · Decibel Therapeutics, Inc. · Filed Feb 19, 2021
Insider Transaction Report
Form 4
Exter Neil
Director10% Owner
Transactions
- Conversion
Common Stock
2021-02-17+2,938,945→ 2,986,114 total(indirect: See footnote) - Conversion
Common Stock
2021-02-17+98,929→ 3,085,043 total(indirect: See footnote) - Conversion
Common Stock
2021-02-17+54,642→ 3,139,685 total(indirect: See footnote) - Conversion
Series A Preferred Stock
2021-02-17−45,638,882→ 0 total(indirect: See footnote)→ Common Stock (2,938,945 underlying) - Conversion
Series D Preferred Stock
2021-02-17−289,603→ 0 total(indirect: See footnote)→ Common Stock (54,642 underlying) - Conversion
Series C Preferred Stock
2021-02-17−1,250,000→ 0 total(indirect: See footnote)→ Common Stock (98,929 underlying)
Footnotes (4)
- [F1]On February 17, 2021, the Series A Preferred Stock automatically converted into Common Stock on a 15.529-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F2]On February 17, 2021, the Series C Preferred Stock automatically converted into Common Stock on a 12.6352-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F3]On February 17, 2021, the Series D Preferred Stock automatically converted into Common Stock on a 5.3-for-one basis without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
- [F4]Held of record by Third Rock Ventures III, L.P. ("TRV III"). The Reporting Person is a partner of Third Rock Ventures GP III, L.P., which is the general partner of TRV III. The Reporting Person disclaims beneficial ownership over such shares, except to the extent of his pecuniary interest therein, if any, and this report shall not be deemed an admission that he is the beneficial owner of such shares.